Fact CheckerSign in

NCT06226779Completed

Baduanjin Versus Brisk Walking for Cognition in Schizophrenia

Mindful Exercise Baduanjin Versus Brisk Walking for Cognitive Function in Patients With Schizophrenia

Source: ClinicalTrials.gov · Last updated 29 Jul 2025

Brief summary (registry, in English)

The current study intends to recruit participants with schizophrenia for the practice of Baduanjin, brisk walking, and health education after enrollment. The study also including a maintenance program. Cognitive and physical function assessments will be conducted before, after, and during follow-up tests. The research hypothesis posits that both Baduanjin and brisk walking will confer beneficial effects on various aspects of cognitive and physical functions.

Status (registry)
Completed
Study type
Interventional
Enrollment
63 (actual)
First submitted
18 Jan 2024
Start date
16 Jan 2024
Primary completion date
15 Jan 2025
Lead sponsor
Chang Gung Memorial Hospital
NCT number
NCT06226779

What you commit to

  • Study type: Interventional
  • Participants enrolled: 63
  • From 16 Jan 2024 to the primary completion date, 15 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Serious physical conditions that will impede participation, such as cardiovascular disease, musculoskeletal disease or pulmonary system disease.
  • Visual or auditory impairment that precludes completion of assessment.

Other

  • Acute psychosis requiring hospitalization.
  • Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.

Who the study is looking for

  • Having a diagnosis of schizophrenia according to the DSM-5.
  • Who will be above 20-65 years of age .
  • Having a stable mental status without shift in medication and keep in same dose for at least one month.
  • Being able to walk independently for 50 meters.

Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chang Gung Memorial Hospital, Kaohsiung Medical Center
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.